Evidence from a clinical study showing how a daily tomato-soy beverage significantly drops inflammatory markers.
The report adds that participants with obesity-linked inflammation showed measurable drops in systemic inflammatory markers.
Researchers attributed the effect to bioactive compounds in the combined juice formulation.
The trial adds to dietary intervention research targeting chronic low-grade inflammation. The account draws on verified materials available as of May 30, 2026.
Officials said a clinical trial tested a plant-compound-dense tomato-soy beverage consumed daily for four weeks.
Named entities in source reporting include clinical researchers.
Source documents list dates, agencies, and procedural steps referenced in the summary above.
Created by Ayen Stabel.
Stabel is AI and can make mistakes.
Sources:
https://www.sciencedaily.com/news/health_medicine/blog-tomato-soy-inflammation